Jong-Seok Kim Selected Research

Jong-Seok Kim Research Topics

Disease

9	Infections 02/2022 - 01/2015
9	Neoplasms (Cancer) 01/2021 - 11/2007
7	Tuberculosis (Tuberculoses) 01/2019 - 12/2011
6	Colonic Neoplasms (Colon Cancer) 10/2015 - 11/2007
3	Inflammation (Inflammations) 01/2021 - 02/2015
2	Body Weight (Weight, Body) 04/2022 - 01/2021
2	Hypoxia (Hypoxemia) 01/2021 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 05/2020
2	Necrosis 01/2013 - 06/2012
1	Colitis 04/2022
1	Ulcerative Colitis 04/2022
1	Sepsis (Septicemia) 02/2022
1	Wound Infection (Wound Infections) 02/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Obesity 01/2021
1	Amyloid Plaque 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 10/2020
1	Premature Birth (Birth, Premature) 10/2020
1	Endometrial Neoplasms (Endometrial Cancer) 09/2020
1	Endometriosis 01/2019
1	Hyperammonemia 01/2018
1	Hepatic Encephalopathy 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Starvation 01/2018
1	Pneumonia (Pneumonitis) 05/2016
1	Iron Deficiencies 09/2015
1	Malnutrition (Nutritional Deficiencies) 09/2015
1	Pulmonary Tuberculosis 01/2015

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 04/2022 - 03/2009
6	VaccinesIBA 01/2019 - 01/2015
4	CytokinesIBA 04/2022 - 01/2013
3	Biological ProductsIBA 01/2021 - 09/2008
3	AntigensIBA 01/2018 - 12/2011
3	TubulinIBA 01/2014 - 11/2007
3	apicularen AIBA 01/2014 - 11/2007
2	RNA (Ribonucleic Acid)IBA 04/2022 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2015
2	InterleukinsIBA 01/2021 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2021 - 03/2009
2	Polysaccharides (Glycans)IBA 01/2021 - 07/2011
2	Docosahexaenoic AcidsIBA 05/2020 - 01/2011
2	CateninsIBA 07/2011 - 01/2011
1	itaconic acidIBA 04/2022
1	Dextrans (Dextran)FDA Link 04/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 04/2022
1	ChemokinesIBA 04/2022
1	4-octyl itaconateIBA 04/2022
1	aconitate decarboxylaseIBA 04/2022
1	Glucose (Dextrose)FDA LinkGeneric 02/2022
1	PolyphenolsIBA 01/2021
1	cinnamic acidIBA 01/2021
1	vitexinIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Chlorogenic AcidIBA 01/2021
1	Ellagic AcidIBA 01/2021
1	amlexanox (Aphthasol)FDA Link 01/2021
1	InflammasomesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	SaponinsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2021
1	LipopolysaccharidesIBA 10/2020
1	acteosideIBA 10/2020
1	TOR Serine-Threonine KinasesIBA 09/2020
1	MTOR InhibitorsIBA 09/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 09/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 05/2020
1	BCG Vaccine FDA Link 01/2019
1	Toll-Like Receptor 2IBA 01/2019
1	Malate Dehydrogenase (Dehydrogenase, Malate)IBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Cytochromes c (Cytochrome c)IBA 01/2018
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2018
1	Nortriptyline (Aventyl)FDA LinkGeneric 01/2018
1	Liposomes (Liposome)IBA 05/2016
1	dimethyldioctadecylammonium (dimethyldioctadecylammonium chloride)IBA 05/2016
1	monophosphoryl lipid AIBA 05/2016
1	Subunit VaccinesIBA 05/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Toll-Like Receptor AgonistsIBA 10/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2015
1	IronIBA 09/2015
1	Interferon-gamma (Interferon, gamma)IBA 04/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015
1	N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA 02/2015
1	AT 112IBA 01/2015
1	AerosolsIBA 01/2015
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2015
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2015
1	Transfer RNA (tRNA)IBA 01/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2014

Therapy/Procedure

5	Therapeutics 04/2022 - 01/2011
1	Catheters 02/2022
1	Activities of Daily Living (ADL) 10/2020
1	Intraperitoneal Injections 10/2020
1	Immunotherapy 10/2015
1	Combination Drug Therapy (Combination Chemotherapy) 01/2015